by Arthur Hailey ‧ RELEASE DATE: Oct. 12, 1984
No, not a doctor/hospital novel--but a Hailey overview of the pharmaceuticals industry, as seen through the very noble career (1957-1985) of maverick/rebel company-woman Celia Jordan. Celia is one of the industry's few female ""detail men""--salespeople--when she marries young Dr. Andrew Jordan in 1957: they meet and fall in love when Celia (pushy) helps Andrew (skeptical) save the life of a dying young woman with Lotromycin, a brand new drug from Felding-Roth. In the decades that follow, however, Celia's--and Hailey's--emphasis will be on the less miraculous aspects of the industry. Thanks to rising exec Celia, Felding-Roth doesn't market Thalidomide in America. She risks her job by publicly calling for ""detail men"" to be more honest and well-informed when hawking their wares to doctors. Put in charge of over-the-counter drugs, she disapproves of hyped-up placebos--but comes up with brilliant ad campaigns. (In Harley's occasionally awful prose: ""And while Celia and O-T-C were meshed fructiferously, events elsewhere moved on as always--with tragedy, comedy, conflict, nobility, sadness, laughter and human folly. . . ."") She and Andrew have a rare spat--when his hospital colleague turns out to be a pill-popping addict/madman. . . and when she relaxes her ethical standards in dealing with lax governments in South America. (Is the drug industry--with its free samples galore--partly to blame for M.D. addicts?) Then, in the 1970s, Celia takes over the research division: she sets up a new lab in England (and has her one extramarital fling with young Dr. Martin Peat-Smith); she spars with bitter, obsessed US researcher Vincent Lord; she debates the profit-vs.-progress research issues, e.g. the money poured into development of ""me-too"" drugs. And the final chapters revolve around two ill-fated drugs: a morning-sickness cure called Montayne (which might cause mental retardation) leads to Celia's high-minded resignation and the suicide of her beloved mentor; then, when Celia has returned to head the company, another false panacea leads to deaths, scandal, and congressional investigation. (Ruthless researcher Victor bribed an FDA official.) Still, the conclusion is upbeat: ""Successful, useful drugs outnumber losers."" And, while some readers will be disappointed by the lack of action and personality (the Celia/Andrew marriage is a heavy dose of glucose), there's a reasonably balanced viewpoint here, a steady parade of issues, and a fair measure of nuts-and-bolts information--sure to please those who relished the industrial-primer approach in Wheels, Overload, and The Moneychangers.
Pub Date: Oct. 12, 1984
ISBN: 1423371518
Page Count: -
Publisher: Doubleday
Review Posted Online: N/A
Kirkus Reviews Issue: Sept. 15, 1984
Categories: FICTION
© Copyright 2025 Kirkus Media LLC. All Rights Reserved.
Hey there, book lover.
We’re glad you found a book that interests you!
We can’t wait for you to join Kirkus!
It’s free and takes less than 10 seconds!
Already have an account? Log in.
OR
Trouble signing in? Retrieve credentials.
Welcome Back!
OR
Trouble signing in? Retrieve credentials.
Don’t fret. We’ll find you.